Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Once and future Chief Counsel

This article was originally published in The Tan Sheet

Executive Summary

Gerald Masoudi returns from the Justice Department to become FDA chief counsel/associate general counsel effective Oct. 12. He replaces Sheldon Bradshaw, who left the agency Sept. 12 to join the Washington, D.C. firm Hunton & Williams (1"The Tan Sheet" Sept. 10, 2007, In Brief). The role will be a familiar one for Masoudi, who came to FDA in 2004 as deputy chief counsel and was acting chief counsel for several months before Bradshaw was named to the post (2"The Tan Sheet" April 11, 2005, p. 7). Since 2005, Masoudi has been deputy assistant attorney general in charge of International, Policy and Appellate Matters in the Antitrust Division at the U.S. Department of Justice. Before joining FDA, Masoudi was a partner at Kirkland & Ellis, where his background included antitrust work (3"The Tan Sheet" Nov. 15, 2004, p. 12)...

You may also be interested in...



People In Brief

Novartis promotes Symonds: Jonathan Symonds will succeed current Novartis Chief Financial Officer Raymund Breu after he retires in March 2010, the Swiss firm announces May 13. Symonds, currently managing director of investment banking at Goldman Sachs, will start as deputy CFO and CFO-designate Sept. 1. Symonds previously was CFO at AstraZeneca for eight years

Chief counsel leaves FDA

Sheldon Bradshaw, chief counsel of FDA, resigned from the agency Sept. 6 to join Hunton & Williams' food and drug law practice, according to the firm. A former Justice Department attorney, Bradshaw served as top lawyer at FDA since 2005, replacing Dan Troy (1"The Tan Sheet" April 11, 2005, p. 7). During his tenure, he reviewed and approved regulations and guidance including a proposed rule clarifying information included in new dietary ingredient notifications and a draft guidance on the kind of scientific data the FDA's Center for Food Safety and Applied Nutrition would find useful in new dietary ingredient submissions. Deputy Chief Counsel Jeffrey Senger will serve as acting chief until a permanent replacement is found, according to FDA staffers in the Office of Chief Counsel...

FDA Chief Counsel Bradshaw Brings DoJ Experience

Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel

Related Content

Topics

UsernamePublicRestriction

Register

PS101029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel